Peripheral and Central Nervous System Drugs Advisory Committee voted based on data from large global confirmatory Phase 3 Clarity AD clinical trial in patients living with early Alzheimer’s disease The PDUFA action date for traditional approval of LEQEMBI has been set for July 6, 2023, with designation of priority review LEQEMBI received accelerated approval from the FDA for the treatment of ...
Transaction in Own Shares June 09, 2023. . Shell plc (SHEL) announces that on 09 June 2023 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 4 May 2023.
EB5 Capital announced today that investors in its Downtown Los Angeles Proper Hotel project have begun receiving I-829 approvals from the United States Citizenship and Immigration Services. An I-829 approval is a major milestone in the EB-5 immigration and investment process, said Mariana Gomez, Senior Vice President of Operations and Compliance.
SAMPO PLC STOCK EXCHANGE RELEASE 09/06/2023 at 08:30 am. Sampo plcs share buybacks 08/06/2023 On 08/06/2023 Sampo plc has acquired its own A shares as follows: . *rounded to two decimals . On 29 March 2023, Sampo announced a share buyback programme of up to a maximum of EUR 400 million in compliance with the Market Abuse Regulation 596/2014...
In May, EfTEN Real Estate Fund AS consolidated rental income was 2,554 thousand euros, i.e., 12 thousand euros more than in April. In May, the fund's subsidiary entered into an agreement with the tenant of the Betoon 6 logistics center to expand the rental area of the building by 739.2 m2. Interest expenses increased in May to 638 thousand euros.
Please find attached the 2023 version of the Salmon Farming Industry Handbook. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachment
Transaction in Own Shares June 08, 2023. . Shell plc (SHEL) announces that on 08 June 2023 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 4 May 2023.
. . ABC arbitrage - Pace of activity as of May 31, 2023 . Through this press release, ABC arbitrage wishes to provide all its shareholders, whether present or not at the Group's Annual General Meeting, with the same level of information ahead of the opening of the debates, which will begin on June 9 at 10.30 am. . Context and activity in the first months of 2023 As at May 31, 2023, the Grou...
Fewer than 26% of Chinese Patients with Atrial Fibrillation are Prescribed an Anticoagulant, while in Japan Almost One-Third of Patients are Undertreated Approximately 63% of Cancer Patients in China Experienced a Venous Thromboembolism within the First 6 Months of Diagnosis Abelacimab is Already Being Studied in 23 Countries throughout North America, Europe, and Elsewhere in the Asia Pacific R...
Enochian BioSciences Inc. (ENOB) announces that it remains confident in submitting an Investigational New Drug Application for its innovative Cancer Platform in early/mid 2024 following review of comments made by the US Food and Drug Administration on the Companys Pre-IND submission.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
Log In Required
Line of Credit Log In Required